KeyBanc on Alignment Healthcare (ALHC): '2026 MLR Optics May Create Buying Opportunity'

KeyBanc analyst Matthew Gillmor reiterated an Overweight rating and $28.00 price target on Alignment Healthcare Inc (NASDAQ: ALHC).

The analyst commented: "Finishing Strong, 2026 MLR Optics May Create Buying Opportunity; 4Q results were strong, highlighted by a meaningful EBITDA beat and wellcontrolled medical costs. Hospital ADK remained in the low 140s and guidance was slightly better than the preview. Importantly, ALHC sounded confident in progressing margins during '27 even with a muted MA rate update. Despite the positives, ALCH's stock traded down 5-7% after-market. We suspect this reflects '26 MLR optics and would use weakness as a buying opportunity. Our positive thesis remains focused on the ability of ALHC's integrated MA-VBC platform to drive better outcomes and share gains while inflecting EBITDA."

For an analyst ratings summary and ratings history on Alignment Healthcare Inc click here. For more ratings news on Alignment Healthcare Inc click here.

Shares of Alignment Healthcare Inc closed at $20.42 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker